Olympus Corporation ( OLYMY) - Key Metrics
OLYMY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | $226.50 | $18 | $13.50 | -$1.81 |
| 2025Q4 | $273.09 | $22.95 | $38.20 | $28.53 |
| 2025Q3 | $241.32 | $13.10 | $36.55 | $26.30 |
| 2025Q2 | $221.99 | $18.09 | $33.65 | $15.07 |
| 2025Q1 | $182.65 | $7.95 | -$13.45 | -$25.01 |
OLYMY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | 172.93% | 23.91 |
| 2025Q4 | 2.28% | 16.99 |
| 2025Q3 | 2.96% | 37.93 |
| 2025Q2 | 0.39% | 25.76 |
| 2025Q1 | 250.87% | 53.33 |
OLYMY Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -0.11% | 1.83% |
| 2025Q4 | 1.88% | 0.03% |
| 2025Q3 | 1.32% | 0.02% |
| 2025Q2 | 0.81% | 0.00% |
| 2025Q1 | -1.47% | 1.18% |
OLYMY
Price: $13.60
52 week price:
Dividend Yield: 1.43%
Payout Ratio Range:
Earnings Per Share: 0.38 USD
P/E Ratio: 34.08
Exchange: PNK
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 13.8 billion